Circulating HIV-1-infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Acquired Immune Deficiency Syndromes

• Publication date

  1994-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 7907663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals

  1993cited by this paper
• Predictors of rapid progression to AIDS in HIV-1 seroconverters.

  1993cited by this paper
• Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

  1993cited by this paper
• High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.

  1993cited by this paper
• HIV-1 PCR and isolation in seroconverting and seronegative homosexual men: absence of long-term immunosilent infection.

  1993cited by this paper
• Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats.

  1993cited by this paper
• HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

  1993cited by this paper
• Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection

  1993cited by this paper
• Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.

  1993cited by this paper
• Quantification and comparison of HIV-1 proviral load in peripheral blood mononuclear cells and isolated CD4+ T cells.

  1993cited by this paper
• The immunopathogenesis of human immunodeficiency virus infection.

  1993cited by this paper
• Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.

  1992cited by this paper
• Plasma HIV-1 Viremia in HIV-1 Infected Individuals Assessed by Polymerase Chain Reaction

  1992cited by this paper
• Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease

  1992cited by this paper
• HIV1 quantitation in infected patients: a comparison of cell viraemia, plasma viraemia and R-HEV.

  1992cited by this paper
• HIV‐1 viral DNA load in peripheral blood mononuclear cells from seroconverters and long‐term infected individuals

  1992cited by this paper
• Prognostic indicators for development of AIDS among intravenous drug users.

  1992cited by this paper
• Absence of HIV-1 DNA in high-risk seronegative individuals using high-input polymerase chain reaction.

  1991cited by this paper
• High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.

  1991cited by this paper
• Quantitative assessment of HIV-1 DNA load by coamplification of HIV-1 gag and HLA-DQ-alpha genes.

  1991cited by this paper
• The initial immune response to HIV and immune system activation determine the outcome of HIV disease.

  1991cited by this paper
• Primary HIV infection: host responses and intervention strategies.

  1991cited by this paper
• Clinical correlation and genetic polymorphism of the human immunodeficiency virus proviral DNA obtained after polymerase chain reaction amplification.

  1990cited by this paper
• Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study.

  1990cited by this paper
• Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease.

  1990cited by this paper
• The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.

  1990cited by this paper
• Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.

  1989cited by this paper
• A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.

  1989cited by this paper
• Clinical course of primary HIV infection: consequences for subsequent course of infection.

  1989cited by this paper
• Plasma viremia in human immunodeficiency virus infection.

  1989cited by this paper
• Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men.

  1989cited by this paper
• Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort

  1988cited by this paper

• Table of Contents

  2019cites this paper
• Regional brain volumetric changes despite two years of treatment initiated during acute HIV infection.

  2019cites this paper
• Comparison of antiviral resistance across acute and chronic viral infections

  2018cites this paper
• Assessment of HIV infection in cells of infected individuals

  2017cites this paper
• The EBV-HIV interrelationship and the value of EBV-DNA analysis

  2012cites this paper
• Estudio de los cambios virológicos y de inmunidad celular en tejido amigdalar tras tratamiento antiretroviral en pacientes infectados por HIV en estado temprano de la infección

  2007cites this paper
• Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa.

  2005cites this paper
• Current Medical Research and Opinion

  2004cites this paper
• HIV-1: maternal prognosis.

  2004cites this paper
• Kinetics of Lymphocyte Proliferation during Primary Immune Response in Macaques Infected with Pathogenic Simian Immunodeficiency Virus SIVmac251: Preliminary Report of the Effect of Early Antiviral Therapy

  2003cites this paper
• Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.

  2001cites this paper
• Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy

  2001cites this paper
• Virologic and regimen termination surrogate end points in AIDS clinical trials.

  2001cites this paper
• Feline Immunodeficiency Virus Clade C Mucosal Transmission and Disease Courses

  2000cites this paper
• Diagnosis of HIV infection in children.

  2000cites this paper
• Overview of HIV/AIDS, 1999

  2000cites this paper
• Evolving strategies for diagnosing human immunodeficiency virus infection.

  2000cites this paper
• Leucocyte depletion of blood components.

  2000cites this paper
• Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection

  2000cites this paper
• Comparison of viral load and human leukocyte antigen statistical and neural network predictive models for the rate of HIV-1 disease progression across two cohorts of homosexual men.

  1999cites this paper
• HBV viral load within subpopulations of peripheral blood mononuclear cells in HBV infection using limiting dilution PCR.

  1999cites this paper
• HIV-1 RNA levels in an African population-based cohort and their relation to CD4 lymphocyte counts and World Health Organization clinical staging.

  1999cites this paper
• Screening for HBV, HCV and HIV genomes in blood donations: shortcomings of pooling revealed by a multicentre study simulating real-time testing.

  1999cites this paper
• Significance of plasma and peripheral blood mononuclear cell derived HIV-1 sequences in establishing epidemiologic linkage between two individuals multiply exposed to HIV-1.

  1999cites this paper
• A critical analysis of the pharmacology of AZT and its use in AIDS.

  1999cites this paper
• HIV and Aerobic Exercise

  1999cites this paper
• Distribution of HIV type 1 (HIV‐1) in blood components: detection and significance of high levels of HIV‐1 associated with platelets

  1998cites this paper
• Recombinant gp 120 Subunit Vaccines Virus Type 1 while Participating in Trials of Persons Infected by Human Immunodeficiency Immunological and Virological Analyses of

  1998cites this paper
• The influence of pregnancy on human immunodeficiency virus type 1 infection: antepartum and postpartum changes in human immunodeficiency virus type 1 viral load.

  1998cites this paper
• Zidovudine treatment in patients with primary (acute) human immunodeficiency virus type 1 infection: a randomized, double-blind, placebo-controlled trial. DATRI 002 Study Group. Division of AIDS Treatment Research Initiative.

  1998cites this paper
• [Molecular biology and transfusional viral safety].

  1998cites this paper
• Direct HIV cytopathicity cannot account for CD4 decline in AIDS in the presence of homeostasis: a worst-case dynamic analysis.

  1998cites this paper
• Biological and Virologic Characteristics of Primary HIV Infection

  1998cites this paper
• Biologie moléculaire et sécurité virale transfusionnelle

  1998cites this paper
• Asymptomatic Human Immunodeficiency Virus (HIV) Infection: Report of Two Cases Treated with Didanosine and Indinavir

  1998cites this paper
• Transforming laboratory test results to improve clinical outcome predictions in HIV patients. Swiss HIV Cohort Study.

  1998cites this paper
• Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1 while Participating in Trials of Recombinant gp120 Subunit Vaccines

  1998cites this paper
• Lack of associations of chemotactic cytokines with viral burden, disease progression, or lymphocyte subsets in HIV-infected individuals.

  1997cites this paper
• Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994.

  1997cites this paper
• Rapid and sensitive detection of cell‐associated HIV‐1 in latently infected cell lines and in patient cells using sodium‐n‐butyrate induction and RT‐PCR

  1997cites this paper
• Human immunodeficiency virus‐1 infection in neonates: correlation of plasma and cellular viremia and clinical outcome

  1997cites this paper
• CD8+ cell‐mediated immune responses: Relation to disease resistance and susceptibility in lentivirus‐infected primates

  1997cites this paper
• REGULATION OF IgE SYNTHESIS IN AIDS

  1997cites this paper
• Serum levels of virus burden in early-stage human immunodeficiency virus type 1 disease in women.

  1997cites this paper
• Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS

  1997cites this paper
• Early and late HIV‐1 RNA level and its association with other markers and disease progression in long‐term AIDS‐free homosexual men

  1997cites this paper
• Prospective Longitudinal Analysis of Viral Load and Surrogate Markers in Relation to Clinical Progression in HIV Type 1-Infected Persons

  1997cites this paper
• [Characteristics of rapid progressors in HIV infection].

  1997cites this paper
• Retroviruses???Human Immunodeficiency Virus

  1997cites this paper
• A rapid method for comparative quantitative polymerase chain reaction of HIV-1 proviral DNA extracted from cryopreserved brain tissues.

  1997cites this paper
• Prospective cohort study of predictors of incident low back pain in nurses

  1997cites this paper
• Evaluation of the presence of 2‐LTR HIV‐1 unintegrated DNA as a simple molecular predictor of disease progression

  1997cites this paper
• Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group.

  1997cites this paper
• Lack of beta-oxidation defects in human immunodeficiency virus-positive subjects with and without chronic zidovudine exposure.

  1996cites this paper
• Site‐directed serology of HIV‐1 subtype B infection: relation between virus specific antibody levels and disease progression

  1996cites this paper
• Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen.

  1996cites this paper
• Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons

  1996cites this paper
• Toward an Understanding of the Correlates of Protective Immunity to HIV Infection

  1996cites this paper
• Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques.

  1996cites this paper
• Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion.

  1996cites this paper
• Surrogate markers in AIDS research. Is there truth in numbers?

  1996cites this paper
• Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons.

  1996cites this paper
• Viral load and immunophenotype of cells obtained from lymph nodes by fine needle aspiration as compared with peripheral blood cells in HIV-infected patients.

  1996cites this paper
• Fluctuations in steady state level of genomic HIV-1 RNA and replication intermediates related to disease progression rate.

  1996cites this paper
• Is the Nef protein of HIV-1 required for pathogenesis?

  1996cites this paper
• HIV vaccines: where we are and where we are going.

  1996cites this paper
• Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group.

  1996cites this paper
• Relationship between infectious cell-associated human immunodeficiency virus type 1 load, T lymphocyte subsets, and stage of infection in homosexual men.

  1996cites this paper
• Differential effects of interleukin-12, interleukin-15, and interleukin-2 on human immunodeficiency virus type 1 replication in vitro

  1996cites this paper
• HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group.

  1996cites this paper
• Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients.

  1996cites this paper
• Differential Effects of Interleukin-12 , Interleukin-15 , and Interleukin-2 on Human Immunodeficiency Virus Type 1 Replication In Vitro

  1996cites this paper
• Human immunodeficiency virus-1 (HIV-1) gp120 superantigen-binding serum antibodies. A host factor in homosexual HIV-1 transmission.

  1996cites this paper
• Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells.

  1996cites this paper
• Differential Effects of Interleukin-12 , Interleukin-15 , and Interleukin-2 on Human Immunodeficiency Virus Type 1 Replication In Vitro

  1996cites this paper
• Vaccines: new approaches and concepts.

  1996cites this paper
• The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview

  1996cites this paper
• Human immunodeficiency viruses.

  1996cites this paper
• Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus

  1995cites this paper
• High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors

  1995cites this paper
• Testing blood donors for HIV: current controversies.

  1995cites this paper
• HIV-1 Messenger RNA in Peripheral Blood Mononuclear Cells as an Early Marker of Risk for Progression to AIDS

  1995cites this paper
• HIV-1 RNA in blood and pathogenesis of HIV infection.

  1995cites this paper
• Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection.

  1995cites this paper
• Potential applications of proviral load measurement in clinical retrovirology.

  1995cites this paper
• Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels.

  1995cites this paper
• Viral phenotype and genotype as markers in clinical trials.

  1995cites this paper
• Expression of CD25 defines peripheral blood mononuclear cells with productive versus latent HIV infection.

  1995cites this paper
• AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.

  1995cites this paper
• Viral load in peripheral blood mononuclear cells as surrogate for clinical progression.

  1995cites this paper
• Natural history of HIV-1 cell-free viremia.

  1995cites this paper
• Therapeutic interventions in primary HIV infection.

  1995cites this paper
• New virologic tools for the design and analysis of clinical trials.

  1995cites this paper
• Factors associated with changes in the use of antiretroviral therapy by a cohort of homosexual men infected with human immunodeficiency virus type 1.

  1995cites this paper
• Lessons from people with nonprogressive HIV infection.

  1995cites this paper
• Mechanism of HIV persistence: implications for vaccines and therapy.

  1995cites this paper
• AIDS as immune system activation. Key questions that remain.

  1995cites this paper
• Aids as Immune System Activation

  1995cites this paper
• Antibody-dependent cell-mediated cytotoxicity against HIV positive target cells

  1994cites this paper
• Rapid culture and quantitation of human immunodeficiency virus type 1 from patient cells without the use of mitogen-stimulated donor cells.

  1994cites this paper